Geomics Is Eclipsing the Encounter Business

Amisomise sells both encounter and geomics. Encounter still the majority of our revenue, but geomics is growing so rapidly that it will eclipse it in due course. We used some of that b farma money to develop an even additional spatial platform called spatial molecular imagethet which we'll be bringing to market in 20 22. It will help us even further pursue this vision of mapping the universe of biology.